158 related articles for article (PubMed ID: 23419607)
41. Glutathione-dependent reduction of arsenate by glycogen phosphorylase responsiveness to endogenous and xenobiotic inhibitors.
Gregus Z; Németi B
Toxicol Sci; 2007 Nov; 100(1):44-53. PubMed ID: 17693424
[TBL] [Abstract][Full Text] [Related]
42. Structure-activity relationships among 2-substituted 5,6-dichloro-, 4,6-dichloro-, and 4,5-dichloro-1-[(2-hydroxyethoxy) methyl]- and -1-[(1,3-dihydroxy-2-propoxy) methyl]benzimidazoles.
Saluja S; Zou R; Drach JC; Townsend LB
J Med Chem; 1996 Feb; 39(4):881-91. PubMed ID: 8632412
[TBL] [Abstract][Full Text] [Related]
43. The architecture of hydrogen and sulfur σ-hole interactions explain differences in the inhibitory potency of C-β-d-glucopyranosyl thiazoles, imidazoles and an N-β-d glucopyranosyl tetrazole for human liver glycogen phosphorylase and offer new insights to structure-based design.
Kyriakis E; Karra AG; Papaioannou O; Solovou T; Skamnaki VT; Liggri PGV; Zographos SE; Szennyes E; Bokor É; Kun S; Psarra AG; Somsák L; Leonidas DD
Bioorg Med Chem; 2020 Jan; 28(1):115196. PubMed ID: 31767404
[TBL] [Abstract][Full Text] [Related]
44. C-Glucopyranosyl-1,2,4-triazoles As New Potent Inhibitors of Glycogen Phosphorylase.
Bokor E; Docsa T; Gergely P; Somsák L
ACS Med Chem Lett; 2013 Jul; 4(7):612-5. PubMed ID: 24900719
[TBL] [Abstract][Full Text] [Related]
45. Kinetic and crystallographic studies on 2-(beta-D-glucopyranosyl)-5-methyl-1, 3, 4-oxadiazole, -benzothiazole, and -benzimidazole, inhibitors of muscle glycogen phosphorylase b. Evidence for a new binding site.
Chrysina ED; Kosmopoulou MN; Tiraidis C; Kardakaris R; Bischler N; Leonidas DD; Hadady Z; Somsak L; Docsa T; Gergely P; Oikonomakos NG
Protein Sci; 2005 Apr; 14(4):873-88. PubMed ID: 15741340
[TBL] [Abstract][Full Text] [Related]
46. Synthesis of New Series of 2-
Szennyes E; Gyémánt G; Somsák L; Bokor É
Molecules; 2020 Feb; 25(3):. PubMed ID: 32041285
[TBL] [Abstract][Full Text] [Related]
47. Studies on the reversible enzyme reaction of rabbit muscle glycogen phosphorylase b using isothermal titration calorimetry.
Szabó K; Kandra L; Gyémánt G
Carbohydr Res; 2019 May; 477():58-65. PubMed ID: 31005807
[TBL] [Abstract][Full Text] [Related]
48. Synthesis and biological evaluation of ambradiolic acid as an inhibitor of glycogen phosphorylase.
Liu J; Zhang H; Zhu P; Wu X; Yao H; Ye W; Jiang J; Xu J
Fitoterapia; 2015 Jan; 100():50-5. PubMed ID: 25447165
[TBL] [Abstract][Full Text] [Related]
49. Glucopyranosylidene-spiro-benzo[ b][1,4]oxazinones and -benzo[ b][1,4]thiazinones: Synthesis and Investigation of Their Effects on Glycogen Phosphorylase and Plant Growth Inhibition.
Kun S; Kánya N; Galó N; Páhi A; Mándi A; Kurtán T; Makleit P; Veres S; Sipos Á; Docsa T; Somsák L
J Agric Food Chem; 2019 Jun; 67(24):6884-6891. PubMed ID: 31135156
[TBL] [Abstract][Full Text] [Related]
50. Glucose analog inhibitors of glycogen phosphorylases as potential antidiabetic agents: recent developments.
Somsák L; Nagya V; Hadady Z; Docsa T; Gergely P
Curr Pharm Des; 2003; 9(15):1177-89. PubMed ID: 12769745
[TBL] [Abstract][Full Text] [Related]
51. Glucose-based spiro-heterocycles as potent inhibitors of glycogen phosphorylase.
Nagy V; Benltifa M; Vidal S; Berzsényi E; Teilhet C; Czifrák K; Batta G; Docsa T; Gergely P; Somsák L; Praly JP
Bioorg Med Chem; 2009 Aug; 17(15):5696-707. PubMed ID: 19574053
[TBL] [Abstract][Full Text] [Related]
52. Discovering benzamide derivatives as glycogen phosphorylase inhibitors and their binding site at the enzyme.
Chen L; Li H; Liu J; Zhang L; Liu H; Jiang H
Bioorg Med Chem; 2007 Nov; 15(21):6763-74. PubMed ID: 17719791
[TBL] [Abstract][Full Text] [Related]
53. [Synthesis and bioactivity of N- [4- ( benzimidazole-2-thio) phenyl] -N'-alkyl guanidine derivatives].
Xu YG; Xing AM; Hong M; Sun XY
Yao Xue Xue Bao; 2007 Feb; 42(2):152-6. PubMed ID: 17518042
[TBL] [Abstract][Full Text] [Related]
54. Halogen-substituted (C-β-D-glucopyranosyl)-hydroquinone regioisomers: synthesis, enzymatic evaluation and their binding to glycogen phosphorylase.
Alexacou KM; Zhang YZ; Praly JP; Zographos SE; Chrysina ED; Oikonomakos NG; Leonidas DD
Bioorg Med Chem; 2011 Sep; 19(17):5125-36. PubMed ID: 21821421
[TBL] [Abstract][Full Text] [Related]
55. Design and synthesis of novel photoaffinity probes for study of the target proteins of oleanolic acid.
Zhang L; Zhang Y; Dong J; Liu J; Zhang L; Sun H
Bioorg Med Chem Lett; 2012 Jan; 22(2):1036-9. PubMed ID: 22204907
[TBL] [Abstract][Full Text] [Related]
56. Dual-Target Compounds against Type 2
Sipos Á; Szennyes E; Hajnal NÉ; Kun S; Szabó KE; Uray K; Somsák L; Docsa T; Bokor É
Pharmaceuticals (Basel); 2021 Apr; 14(4):. PubMed ID: 33920838
[TBL] [Abstract][Full Text] [Related]
57. Synthesis and β-glucuronidase inhibitory potential of benzimidazole derivatives.
Khan KM; Khan M; Ambreen N; Rahim F; Naureen S; Perveen S; Choudhary MI; Voelter W
Med Chem; 2012 May; 8(3):421-7. PubMed ID: 22530898
[TBL] [Abstract][Full Text] [Related]
58. Modeling aided design of potent glycogen phosphorylase inhibitors.
Deng Q; Lu Z; Bohn J; Ellsworth KP; Myers RW; Geissler WM; Harris G; Willoughby CA; Chapman K; McKeever B; Mosley R
J Mol Graph Model; 2005 Apr; 23(5):457-64. PubMed ID: 15781188
[TBL] [Abstract][Full Text] [Related]
59. Structure based inhibitor design targeting glycogen phosphorylase B. Virtual screening, synthesis, biochemical and biological assessment of novel N-acyl-β-d-glucopyranosylamines.
Parmenopoulou V; Kantsadi AL; Tsirkone VG; Chatzileontiadou DS; Manta S; Zographos SE; Molfeta C; Archontis G; Agius L; Hayes JM; Leonidas DD; Komiotis D
Bioorg Med Chem; 2014 Sep; 22(17):4810-25. PubMed ID: 25092521
[TBL] [Abstract][Full Text] [Related]
60. Synthesis, screening and docking of small heterocycles as glycogen phosphorylase inhibitors.
Schweiker SS; Loughlin WA; Lohning AS; Petersson MJ; Jenkins ID
Eur J Med Chem; 2014 Sep; 84():584-94. PubMed ID: 25062009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
